RY 169.05 -0.512% SHOP 171.48 0.4393% TD 82.4 0.4878% ENB 63.13 0.6858% BN 84.47 0.8116% TRI 241.48 0.3866% CNQ 44.41 0.0225% CP 110.42 0.1269% CNR 146.17 0.3501% BMO 140.7 0.8819% BNS 71.92 0.0696% CSU 4802.5498 0.0531% CM 87.85 -0.5209% MFC 42.725 0.4349% ATD 75.08 -0.8321% NGT 64.54 3.9291% TRP 67.13 0.3888% SU 54.71 0.1098% WCN 269.21 0.1973% L 179.36 -0.6921%
Last update at 2025-02-05T15:19:00Z
HEALWELL AI Announces the Commencement of Trading on OTCQX and Receives DTC Eligibility
Tue 21 Nov 23, 02:26 PMHEALWELL AI Reports Q3-2023 Financial Results
Wed 15 Nov 23, 12:00 PM| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -32.68300M | -17.07600M | -16.28800M | -1.33900M | -0.03000M |
| Minority interest | - | - | - | - | - |
| Net income | -32.19300M | -21.08500M | -15.67000M | -1.02900M | -0.12200M |
| Selling general administrative | 9.06M | 11.36M | 30.18M | 13.61M | 13.53M |
| Selling and marketing expenses | 1.28M | 1.52M | 1.11M | 0.12M | - |
| Gross profit | 1.26M | 3.71M | 15.01M | 64.22M | 15.26M |
| Reconciled depreciation | - | - | - | - | - |
| Ebit | -17.59200M | -17.54800M | -16.43400M | -0.84200M | 0.52M |
| Ebitda | -16.11300M | -15.00800M | -12.12500M | 2.11M | 3.64M |
| Depreciation and amortization | 1.48M | 2.54M | 4.31M | 2.96M | 3.12M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -17.59200M | -17.54800M | -16.43400M | -0.84200M | 0.52M |
| Other operating expenses | 38.66M | 27.74M | 64.26M | 11.91M | 47.58M |
| Interest expense | - | 0.62M | 0.46M | 0.50M | 0.54M |
| Tax provision | - | 1.22M | -0.74700M | -0.31200M | - |
| Interest income | - | 1.03M | 0.35M | 0.06M | - |
| Net interest income | - | - | - | - | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.54M | 1.12M | -0.74700M | -0.31200M | 0.09M |
| Total revenue | 7.32M | 10.42M | 47.82M | 38.57M | 46.29M |
| Total operating expenses | 32.60M | 21.03M | 31.45M | 13.74M | 16.55M |
| Cost of revenue | 6.06M | 6.71M | 32.81M | -25.64900M | 31.03M |
| Total other income expense net | -15.09100M | 0.88M | 0.64M | 0.02M | 1.85M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | - | - | - | - | - |
| Net income applicable to common shares | - | -21.08500M | -15.67000M | -1.02900M | - |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 53.70M | 45.63M | 60.89M | 22.36M | 22.68M |
| Intangible assets | 12.51M | 11.25M | 12.45M | 0.49M | 0.13M |
| Earning assets | - | - | - | - | - |
| Other current assets | 2.35M | 1.17M | 2.50M | 0.87M | 0.04M |
| Total liab | 32.23M | 33.85M | 32.86M | 22.24M | 20.42M |
| Total stockholder equity | 12.65M | 11.78M | 28.03M | 0.11M | 2.14M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 4.82M | - | - | - | 2.05M |
| Common stock | 67.37M | 39.79M | 39.79M | 1.01M | - |
| Capital stock | - | - | - | - | - |
| Retained earnings | -69.24900M | -37.65200M | -16.56700M | -0.89700M | 2.14M |
| Other liab | - | - | - | - | - |
| Good will | 12.30M | 10.07M | 10.07M | 0.15M | 0.15M |
| Other assets | - | 0.47M | 1.95M | 1.06M | - |
| Cash | 19.16M | 1.41M | 7.14M | 0.89M | 1.13M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 9.42M | 19.39M | 14.49M | 10.74M | 7.11M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 0.76M | - | - | - | 14.82M |
| Short term debt | 0.67M | 7.00M | 0.00000M | 1.21M | 2.63M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 19.92M | - | - | - | 15.95M |
| Other stockholder equity | 12.57M | - | - | - | - |
| Property plant equipment | - | 10.44M | 13.93M | 13.57M | - |
| Total current assets | 22.76M | 8.61M | 16.51M | 5.78M | 4.18M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | - | - |
| Short term investments | - | 0.39M | 0.54M | 0.38M | 0.39M |
| Net receivables | 1.24M | 4.29M | 3.22M | 2.21M | 2.62M |
| Long term debt | - | - | - | - | - |
| Inventory | - | - | - | - | 0.00000M |
| Accounts payable | 3.93M | - | - | - | 2.42M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 1.96M | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1.99M | - | - | - | 0.26M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 30.94M | - | - | - | 18.50M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | 9.33M | 11.26M | 11.30M | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | - | - | - | - | - |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | - | -1.16800M | -8.64400M | -0.23400M | - |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | 27.20M | 3.78M | 21.99M | -4.22200M | -2.89100M |
| Change to operating activities | - | - | - | - | - |
| Net income | -31.59700M | -20.97000M | -15.54100M | -1.02700M | -0.12000M |
| Change in cash | 17.75M | -5.73100M | 6.25M | -0.23400M | 0.20M |
| Begin period cash flow | 1.41M | 7.14M | 0.89M | 1.13M | 0.93M |
| End period cash flow | 19.16M | 1.41M | 7.14M | 0.89M | 1.13M |
| Total cash from operating activities | -10.79800M | -8.34600M | -7.09800M | 4.22M | 3.21M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 2.80M | 2.54M | 4.31M | 2.96M | 3.12M |
| Other cashflows from investing activities | - | 0.00000M | -6.27600M | - | - |
| Dividends paid | - | 0.12M | 0.00000M | 2.01M | - |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | 4.51M | 0.69M | -1.50400M | -1.21900M | 0.16M |
| Sale purchase of stock | - | 0.00000M | -0.87000M | - | - |
| Other cashflows from financing activities | 27.60M | -0.11600M | -1.38100M | -0.04300M | -0.31000M |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 0.07M | 1.15M | 2.37M | 0.23M | 0.12M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 4.56M | 2.21M | -1.64800M | 1.73M | -0.66400M |
| Stock based compensation | 3.26M | 4.83M | 6.11M | 0.75M | - |
| Other non cash items | 10.18M | -1.13600M | -0.23100M | 0.04M | 0.46M |
| Free cash flow | -10.86400M | -9.49400M | -9.46600M | 3.99M | 3.09M |
Sector: Healthcare Industry: Medical Care Facilities
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AIDX HealWELL AI Inc. |
-0.03 1.67% | 1.77 | - | - | 20.92 | 5.03 | 20.83 | -4.9271 |
| DNTL dentalcorp Holdings Ltd |
0.06 0.78% | 7.71 | - | 14.68 | 1.05 | 0.89 | 1.88 | 14.19 |
| SIA Sienna Senior Living Inc |
0.07 0.44% | 15.98 | 43.79 | 36.90 | 1.67 | 3.83 | 2.82 | 18.48 |
| WELL WELL Health Technologies Corp |
0.08 1.31% | 6.20 | 17.23 | 18.12 | 1.39 | 1.42 | 1.78 | 5.49 |
| EXE Extendicare Inc |
0.53 5.03% | 11.07 | 14.07 | 15.70 | 0.58 | 7.49 | 0.71 | 7.52 |
Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support platform for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
4881 Yonge Street, Toronto, ON, Canada, M2N 5X3
| Name | Title | Year Born |
|---|---|---|
| Mr. Donald Watts | President of Khure Health | NA |
| Dr. Alexander Julian Dobranowski | Founder, CEO, MD & Director | NA |
| Ms. Madeline D. Walker | President of MCI Medical | 1947 |
| Mr. Anthony Lam | Chief Financial Officer | NA |
| Paulo Gomes | Co-Chief Operating Officer | NA |
| Adam Hutton | Co-Chief Operating Officer | NA |
| Nolan Reeds | Vice President of Marketing & Communications | NA |
| Mr. Blake Corbet | Senior Vice President of Corporate Development | NA |
| Mr. Mark Findlay | Senior Vice President of Sales & Marketing for Canada | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...